Back to Browse Journals » Pharmacogenomics and Personalized Medicine » Volume 5

Pharmacogenomic considerations in opioid analgesia

Authors Vuilleumier PH, Stamer UM, Landau R

Received 27 February 2012

Accepted for publication 16 April 2012

Published 23 August 2012 Volume 2012:5 Pages 73—87


Review by Single-blind

Peer reviewer comments 2

Pascal H Vuilleumier,1 Ulrike M Stamer,1 Ruth Landau2

1Klinik für Anästhesiologie und Schmerztherapie, Inselspital Universität Bern, Switzerland; 2Department of Anesthesiology and Pain Medicine, University of Washington School of Medicine, Seattle, WA, USA

Abstract: Translating pharmacogenetics to clinical practice has been particularly challenging in the context of pain, due to the complexity of this multifaceted phenotype and the overall subjective nature of pain perception and response to analgesia. Overall, numerous genes involved with the pharmacokinetics and dynamics of opioids response are candidate genes in the context of opioid analgesia. The clinical relevance of CYP2D6 genotyping to predict analgesic outcomes is still relatively unknown; the two extremes in CYP2D6 genotype (ultrarapid and poor metabolism) seem to predict pain response and/or adverse effects. Overall, the level of evidence linking genetic variability (CYP2D6 and CYP3A4) to oxycodone response and phenotype (altered biotransformation of oxycodone into oxymorphone and overall clearance of oxycodone and oxymorphone) is strong; however, there has been no randomized clinical trial on the benefits of genetic testing prior to oxycodone therapy. On the other hand, predicting the analgesic response to morphine based on pharmacogenetic testing is more complex; though there was hope that simple genetic testing would allow tailoring morphine doses to provide optimal analgesia, this is unlikely to occur. A variety of polymorphisms clearly influence pain perception and behavior in response to pain. However, the response to analgesics also differs depending on the pain modality and the potential for repeated noxious stimuli, the opioid prescribed, and even its route of administration.

Keywords: pain perception, opioid analgesia, genetic variation, pharmacogenetics

Corrigendum for this paper has been published

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] View Full Text [HTML] 


Other article by this author:

Pharmacogenomic considerations in opioid analgesia. [Corrigendum]

Vuilleumier PH, Stamer UM, Landau R

Pharmacogenomics and Personalized Medicine 2013, 6:1-2

Published Date: 14 January 2013

Readers of this article also read:

Predictors of placebo response in peripheral neuropathic pain: insights from pregabalin clinical trials

Freeman R, Emir B, Parsons B

Journal of Pain Research 2015, 8:257-268

Published Date: 1 June 2015

Do you know where your fillers go? An ultrastructural investigation of the lips

Vent J, Lefarth F, Massing T, Angerstein W

Clinical, Cosmetic and Investigational Dermatology 2014, 7:191-199

Published Date: 20 June 2014

Conformational changes of fibrinogen in dispersed carbon nanotubes

Park SJ, Khang D

International Journal of Nanomedicine 2012, 7:4325-4333

Published Date: 6 August 2012

Susceptibility of Propionibacterium acnes isolated from patients with acne vulgaris to zinc ascorbate and antibiotics

Iinuma K, Noguchi N, Nakaminami H, Sasatsu M, Nishijima S, Tsuboi I

Clinical, Cosmetic and Investigational Dermatology 2011, 4:161-165

Published Date: 5 October 2011

TachoSil use in abdominal surgery: a review

Adriana Toro, Maurizio Mannino, Giulio Reale, et al

Journal of Blood Medicine 2011, 2:31-36

Published Date: 14 March 2011

Novel drug-eluting stents in the treatment of de novo coronary lesions

Davide Capodanno, Fabio Dipasqua, Corrado Tamburino

Vascular Health and Risk Management 2011, 7:103-118

Published Date: 25 February 2011

Pace bowlers in cricket with history of lumbar stress fracture have increased risk of lower limb muscle strains, particularly calf strains

John Orchard, Patrick Farhart, Alex Kountouris, et al

Open Access Journal of Sports Medicine 2010, 1:177-182

Published Date: 9 September 2010